To reveal specific plasma metabolomic changes related to sarcopenia in older patients with sepsis, highlighting the potential for improved patient outcomes.
Metabolic profile of sarcopenic patients showed an 'inhibitory' feature, suggesting a need for targeted therapies.
Core pathways affected include valine/leucine/isoleucine degradation, arachidonic acid metabolism, and steroid hormone synthesis, which may inform future research.
Interpretation:
The unique plasma metabolic profile in elderly sepsis patients with sarcopenia indicates metabolic imbalances, particularly in muscle synthesis pathways and inflammatory responses, suggesting avenues for clinical intervention.
Limitations:
Study conducted in a single center, limiting generalizability; future multi-center studies are recommended.
Small sample size may affect the robustness of findings; larger studies are needed to validate results.
Conclusion:
The study highlights the metabolic characteristics of sarcopenia in elderly patients with sepsis, providing insights for potential diagnostic biomarkers and intervention strategies that could improve patient outcomes.
